We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for etranacogene dezaparvovec (CSL Behring Australia Pty Ltd)
Active ingredients
etranacogene dezaparvovec
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Indication
For the treatment of haemophilia B
Therapeutic area
Haematology